D’Arcy v. Myriad Genetics: A Demand for the “Made” or “Non-Information” and Clear Subject Matter?
In October 2015, the High Court of Australia (HCA) handed down D’Arcy v. Myriad Genetics and overturned the Full Court of the Federal Court of Australia by holding that key product claims from Myriad Genetics’ BRCA1 gene patent did not constitute manners of manufacture. Two years earlier, the Suprem...
Saved in:
Published in | IIC - International Review of Intellectual Property and Competition Law Vol. 47; no. 5; pp. 537 - 568 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.08.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!